SunBio,Inc. (KOSDAQ:067370)

South Korea · Delayed Price · Currency is KRW

5,720.00

-440.00 (-7.14%)

At close: Jul 20, 2026

-17.82% (1Y)

Market Cap	69.75B -18.6%
Revenue (ttm)	2.17B +2.3%
Net Income	1.39B
EPS	249.33
Shares Out	12.19M
PE Ratio	22.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,560
Open	6,200.00
Previous Close	6,160.00
Day's Range	5,470.00 - 6,200.00
52-Week Range	4,840.00 - 8,500.00
Beta	0.60
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SunBio,Inc.

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1997

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 067370

Full Company Profile